REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 167 filers reported holding REATA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 2.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $682,000 | +96.0% | 20,815 | +746.5% | 0.05% | +47.1% |
Q2 2021 | $348,000 | -69.8% | 2,459 | -56.4% | 0.03% | -69.6% |
Q4 2019 | $1,152,000 | +102.5% | 5,634 | -20.5% | 0.11% | +154.5% |
Q3 2019 | $569,000 | +1.1% | 7,085 | +7.5% | 0.04% | +37.5% |
Q1 2019 | $563,000 | – | 6,591 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |